{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:46:26Z","timestamp":1788309986434,"version":"build-2803163510"},"reference-count":14,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2020,5,20]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Histone deacetylases inhibitors (HDACIs) with different chemical structures\nhave been reported to play an important role in the treatment of cancer.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The study aims to modify the structure of Entinostat (MS-275) to discover new compounds\nwith improved anti-proliferative activities and perform SAR studies on this class of bioactive\ncompounds.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Fourteen N-substituted benzamide derivatives were synthesized and their antiproliferative\nactivities were tested with four cancer cell lines (MCF-7, A549, K562 and MDA-MB-\n231) by MTT assay.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Compared with MS-275, six compounds exhibited comparable or even better antiproliferative\nactivities against specific\/certain cancer cell lines.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The preliminary SARs showed that (\u2170) the 2-substituent of the phenyl ring in the R\ngroup and heteroatoms of amide which can chelate with zinc ion are critical to the antiproliferative\nactivity and (\u2171) chlorine atom or nitro-group on the same benzene ring largely decreases\ntheir anti-proliferative activity. Molecular docking study illustrated the interaction (binding\naffinity) between the synthesized compounds and HDAC2 was observed to be similar to that of\nMS-275.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406415666190712120611","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T12:45:13Z","timestamp":1563281113000},"page":"555-562","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Synthesis of N-Substituted Benzamide Derivatives and their Evaluation as Antitumor Agents"],"prefix":"10.2174","volume":"16","author":[{"given":"Taiping","family":"Chen","sequence":"first","affiliation":[{"name":"School of Chemical Engineering, Sichuan University, Chengdu 610065, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwu","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Chemical Engineering, Sichuan University, Chengdu 610065, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Chemical Engineering, Sichuan University, Chengdu 610065, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zicheng","family":"Li","sequence":"additional","affiliation":[{"name":"School of Chemical Engineering, Sichuan University, Chengdu 610065, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencai","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Chemical Engineering, Sichuan University, Chengdu 610065, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfu","family":"Luo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Chengdu 610041, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglan","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Chengdu 610041, Sichuan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.2174\/092986711795471284","volume":"18","author":"Venugopal B.","year":"2011","unstructured":"Venugopal B.; Evans T.R.J.; Developing histone deacetylase inhibitors as anti-cancer therapeutics. Curr Med Chem 2011,18(11),1658-1671","journal-title":"Curr Med Chem"},{"key":"ref=2","first-page":"166","volume":"3","author":"Kim H.J.","year":"2011","unstructured":"Kim H.J.; Bae S.C.; Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 2011,3(2),166-179","journal-title":"Am J Transl Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1016\/j.bmc.2017.03.036","volume":"25","author":"Gao S.","year":"2017","unstructured":"Gao S.; Zang J.; Gao Q.; Liang X.; Ding Q.; Li X.; Xu W.; Chou C.J.; Zhang Y.; Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups. Bioorg Med Chem 2017,25(12),2981-2994","journal-title":"Bioorg Med Chem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3390\/ph3082441","volume":"3","author":"Ellis L.","year":"2010","unstructured":"Ellis L.; Pili R.; Histone deacetylase inhibitors: advancing therapeutic strategies in hematological and solid malignancies. Pharmaceuticals (Basel) 2010,3(8),2411-2469","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2174\/138955711795843347","volume":"11","author":"Petrella A.","year":"2011","unstructured":"Petrella A.; Fontanella B.; Carrat\u00f9 A.; Bizzarro V.; Rodriquez M.; Parente L.; Histone deacetylase inhibitors in the treatment of hematological malignancies. Mini Rev Med Chem 2011,11(6),519-527","journal-title":"Mini Rev Med Chem"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.apsb.2011.10.002","volume":"1","author":"Lu H.","year":"2011","unstructured":"Lu H.; Chen Y.D.; Yang B.; You Q.D.; Design, synthesis and biological evaluation of novel histone deacetylase inhibitors based on virtual screening. Acta Pharm Sin B 2011,1(4),240-247","journal-title":"Acta Pharm Sin B"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1517\/13543770903393789","volume":"19","author":"Wang H.","year":"2009","unstructured":"Wang H.; Dymock B.W.; New patented histone deacetylase inhibitors. Expert Opin Ther Pat 2009,19(12),1727-1757","journal-title":"Expert Opin Ther Pat"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/bjc.2013.742","volume":"110","author":"Sonnemann J.","year":"2014","unstructured":"Sonnemann J.; Marx C.; Becker S.; Wittig S.; Palani C.D.; Kr\u00e4mer O.H.; Beck J.F.; p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors. Br J Cancer 2014,110(3),656-667","journal-title":"Br J Cancer"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1021\/jm0605536","volume":"49","author":"Mai A.","year":"2006","unstructured":"Mai A.; Massa S.; Rotili D.; Simeoni S.; Ragno R.; Botta G.; Nebbioso A.; Miceli M.; Altucci L.; Brosch G.; Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors. [J]. J Med Chem 2006,49(20),6046-6056","journal-title":"J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1039\/C5MD00247H","volume":"6","author":"Zhang X.","year":"2015","unstructured":"Zhang X.; Lv P.C.; Li D.D.; Zhang W.M.; Zhu H.L.; Navigating into the chemical space between MGCD0103 and SAHA: novel histone ceacetylase inhibitors as a promising lead. MedChemComm 2015,6(10),1816-1825","journal-title":"MedChemComm"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/517295","volume":"2015","author":"Cai J.","year":"2015","unstructured":"Cai J.; Zhang Q.; Lin K.; Hu L.; Zheng Y.; The effect of MGCD0103 on CYP450 isoforms activity of rats by cocktail method. BioMed Res Int 2015,2015(7)","journal-title":"BioMed Res Int"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1021\/jm980565u","volume":"42","author":"Suzuki T.","year":"1999","unstructured":"Suzuki T.; Ando T.; Tsuchiya K.; Fukazawa N.; Saito A.; Mariko Y.; Yamashita T.; Nakanishi O.; Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. J Med Chem 1999,42(15),3001-3003","journal-title":"J Med Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"12316","DOI":"10.1021\/bi050801k","volume":"44","author":"Irwin J.J.","year":"2005","unstructured":"Irwin J.J.; Raushel F.M.; Shoichet B.K.; Virtual screening against metalloenzymes for inhibitors and substrates. Biochemistry 2005,44(37),12316-12328","journal-title":"Biochemistry"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1021\/jm701500e","volume":"51","author":"Babaoglu K.","year":"2008","unstructured":"Babaoglu K.; Simeonov A.; Irwin J.J.; Nelson M.E.; Feng B.; Thomas C.J.; Cancian L.; Costi M.P.; Maltby D.A.; Jadhav A.; Inglese J.; Austin C.P.; Shoichet B.K.; Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase. J Med Chem 2008,51(8),2502-2511","journal-title":"J Med Chem"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/173428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:57:46Z","timestamp":1594958266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/173428\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,20]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406415666190712120611","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-11-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}